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Balancing the Risks and Benefits of Chronic Nitrate Use
Organic nitrates remain among the oldest and most commonly used drugs fortreating angina and heart failure.However, recent observations suggest that they
may provoke endothelial and autonomic dysfunction via the production of reactive
oxygen species. On the other hand, nitrates have been demonstrated to have protective
effects that mimic those of ischemic preconditioning. Gori and Parker review the
current understanding of chronic nitrate use and suggest the need for randomized
long-term studies of their safety and efficacy. See page 251.
Page 259
Coronary Artery Disease
IVUS Demonstrates the Effect of Diabetes on Atherosclerosis
Nicholls and colleagues compiled intravascular ultrasound (IVUS) results fromover 2,000 subjects enrolled in several large studies that included serial IVUS
examinations. Diabetic patients had higher percent atheroma volume (PAV), higher
total atheroma volume (TAV), and a smaller lumen. Diabetic patients hadmore rapid
progression of PAV and TAV and were less likely to have a5% reduction in either
measure with intensive low-density lipoprotein cholesterol (LDL-C) lowering. This
study quantifies the accelerated progression of atherosclerosis in diabetics.See pages
255 and 263. See figure.
Page 270
Heart Failure
Copeptin Helps to Risk Stratify Patients With Chronic Heart Failure
Copeptin is a fragment of pre–pro-vasopressin, which is more stable in vitro, andtherebymore reliably measured, than vasopressin. Neuhold and colleagues mea-
sured copeptin levels in almost 800 patients with varying severity of systolic dysfunc-
tion and other comorbidities.WhileNewYorkHeart Association (NYHA) functional
class was the most potent predictor of 24-month mortality, copeptin identified which
NYHA functional class II and III patients weremost likely to die. InNYHA functional
class IV, serum sodium was the best stratifier, but copeptin added additional informa-
tion. Copeptin was a superior riskmarker than brain natriuretic peptide orN-terminal
pro-B-type natriuretic peptide in this study. See page 266. See figure.
Heart Rhythm Disorders
Circumferential PVI With a Cryoballoon
Neumann and colleagues report their experience with a novel double lumencryoballoon catheter designed for circumferential pulmonary vein isolation
(PVI) in over 300 patients with atrial fibrillation (AF). The primary end points of this
nonrandomized study were acute isolation rate of the targeted pulmonary vein and
recurrence of AF. The secondary end point was procedure related complications.
Ablation with the cryoballoon resulted in maintenance of sinus rhythm in 74% of
patients with paroxysmal AF and 42%with persistent AF. Themost frequent compli-
cation was right phrenic nerve palsy. Pulmonary vein isolation with a new cryoballoon
technique is feasible, although further studies are needed to refine the risks associated
with this technique. See page 273.
(continued) A-24Cardiac Imaging
DCMR Identifies High Risk Patients with LV Dysfunction
Dall’Armellina and colleagues reviewed the dobutamine cardiovascular magneticresonance (DCMR) results from200patientswith ejection fraction (EF)55%
in whom left ventricular (LV) wall motion score index (WMSI) was assessed during
intravenous infusion of dobutamine/atropine. All participants were followed for an
average of 5 years. In subjects with an EF of 40% to 55%, a DCMR stress-induced
change in WMSI added significantly to predicting future cardiac events, but was less
useful than simply measuring the EF in those with an EF40%. In individuals with
mild to moderate reductions in EF (40% to 55%), dobutamine-induced increases in
WMSIpredict cardiac risk better than an assessment of restingLVEF alone.Seepage
279.
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Exercise Hypertension
Exaggerated BP Response to Exercise Associated with Increased
Angiotensin II Release
Shimand colleagues hypothesized that an exaggerated blood pressure (BP) responseto exercise may be due to differences in the release of neurohormones during
exercise. Otherwise healthy and normotensive men and women with an exaggerated
BP response to exercise, defined as an increase from baseline systolic BP60 mmHg
inmen or50mmHg inwomen,were comparedwith subjects with smaller increases
in BP. Angiotensin II levels at rest and at peak exercise and the magnitude of the
increase with exercise were significantly higher in the exaggerated BP response group.
There were no differences in several other neurohormones. Exaggerated BP responses
to exercise appear to be caused by higher levels of angiotensin II. See page 287.
See figure.
Pediatric Cardiovascular
Disease
Childhood Levels of Apolipoproteins B and A-I Predict Future Atherosclerosis
Juonala and colleagues reviewed the results of several cardiac risk factors obtainedwhen subjects were 3 to18 years old with the results of carotid artery intima-media
thickness (IMT) and brachial artery flow-mediated dilation (FMD) 20 years later. In
subjects age 12 to 18 years at baseline, apolipoprotein (apo)B, apoA-I, and the
apoB/apoA-I ratio correlated with adult IMT. The same correlations were found for
subjects ages 3 to 18 years at baseline for FMD. The apoB/apoA-I ratio had better
predictive utility than the low-density lipoprotein/high-density lipoprotein ratio and
than any individual measurement. Measuring apoB and apoA-I in children and
adolescents may identify patients at high risk of atherosclerosis. See pages 293 and
300.
